SCHEMBL9515765

SCHEMBL9515765

CC(=O)OCc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCCCc3ccccc3)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.46
P4HTM Q9NXG6 2/20 0.44
MLYCD O95822 1/20 0.44
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
PTAFR P25105 1/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
EPHX2 P34913 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517158 0.97 NPC1 (0.46) HSP90AA1P4HTMMLYCDBCL2L1MCL1
SCHEMBL9515987 0.94 NPC1 (0.49) P4HTMBCL2L1MCL1NPC1RAB9A
SCHEMBL9519274 0.88 SCN3A (0.51) P4HTMBCL2L1MCL1EPHX2KDM4E
SCHEMBL9517097 0.87 HSP90AA1 (0.51) HSP90AA1P4HTMMLYCDPTAFRNPC1
SCHEMBL9517241 0.84 P4HTM (0.61) P4HTMBCL2L1MCL1
SCHEMBL9517800 0.84 NPC1 (0.52) HSP90AA1P4HTMMLYCDNPC1RAB9A
SCHEMBL9143189 0.84 P4HTM (0.52) HSP90AA1P4HTMMLYCDBCL2L1MCL1
SCHEMBL9517102 0.83 NPC1 (0.49) P4HTMBCL2L1MCL1NPC1RAB9A
SCHEMBL9138472 0.83 P4HTM (0.53) HSP90AA1P4HTMMLYCDPTAFRNPC1
SCHEMBL9018032 0.82 HSP90AA1 (0.46) HSP90AA1P4HTMMLYCDBCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed